Explore high-purity synthesized peptides and specialty fine chemical APIs certified for industrial, analytical, and pharmaceutical developments.
Analyzing global demand shifts, dual-agonist pharmacology, and high-purity supply chains from China's manufacturing hubs.
The therapeutic landscape for metabolic disorders, type 2 diabetes mellitus (T2DM), and chronic weight management has undergone a historic paradigm shift over the past five years. At the center of this revolution is Tirzepatide—a synthetic 39-amino-acid peptide designed as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. As clinical trials consistently demonstrate superior efficacy of the 15mg dosage threshold in maximizing weight loss, improving glycemic control, and lowering cardiovascular risks, global demand for medical-grade Tirzepatide 15mg active pharmaceutical ingredients (APIs) and finished dosage forms (FDF) has skyrocketed.
As a leading China Tirzepatide 15mg Manufacturer & Company, Gentolex is positioned at the intersection of advanced chemical synthesis, large-scale cGMP manufacturing, and global regulatory compliance. Operating from an overall factory construction area of 250,000 square meters built to strict international engineering standards, we provide flexible, scalable, and cost-effective raw peptide APIs, custom peptides synthesis, lyophilized vial formulation, and integrated contract development and manufacturing organization (CDMO) services for pharmaceutical entities worldwide.
Tirzepatide represents a structural masterpiece in peptide engineering. Unlike mono-GLP-1 agonists such as Semaglutide, Tirzepatide’s amino acid sequence is engineered based on the native GIP sequence, modified with a C20 fatty diacid moiety attached via a linker to lysine at position 20. This lipophilic side chain enables strong binding to human serum albumin, extending its terminal half-life to approximately 5 days and permitting convenient once-weekly subcutaneous administration.
| Parameter | Specification & Quality Standard | Analytical Test Method |
|---|---|---|
| Chemical Name | Tirzepatide (Dual GIP/GLP-1 Agonist) | IUPAC / Chemical Abstracts Index |
| CAS Registry Number | 2023788-19-2 | Cross-referenced Registry |
| Dosage Strength | 15mg / lyophilized vial or bulk API powder | Gravimetric / Volumetric Assay |
| Chemical Formula & MW | C225H348N48O68 | Mol Weight: 4813.45 Da | High-Resolution Mass Spectrometry (HRMS) |
| Purity Level (HPLC) | ≥ 99.0% (Custom high-grade batches ≥ 99.5%) | RP-HPLC (Reverse Phase HPLC) |
| Peptide Content (Assay) | ≥ 85.0% - 90.0% net peptide content | Elemental Nitrogen Analysis / UV Spec |
| Impurity Profile | Single Unknown Impurity ≤ 0.5%; Total ≤ 1.5% | LC-MS / High Performance Liquid Chromatography |
| Bacterial Endotoxins | < 5.0 EU/mg (Injectable Grade) | LAL (Limulus Amebocyte Lysate) Assay |
| Residual Solvents / TFA | TFA Content < 1.0%; Solvents within ICH Q3C | Headspace Gas Chromatography (HS-GC) / Ion Chrom |
| Appearance | White to off-white lyophilized, uniform powder | Visual Inspection / Clarity of Solution Test |
Detailed analysis of Solid-Phase Peptide Synthesis (SPPS), fragment condensation, counter-ion exchange, and sterile filling protocols.
Synthesizing long-chain peptides containing complex fatty acid modifications—such as Tirzepatide (39 amino acids with C20 fatty acid linkage)—presents severe technical hurdles in bulk manufacturing. Minor side reactions during coupling steps can produce closely related deletion peptides or diastereomers that are extraordinarily difficult to remove during downstream purification. At Gentolex, our chemical development team utilizes a proprietary hybrid synthesis platform combining Solid-Phase Peptide Synthesis (SPPS) with strategic Liquid-Phase Fragment Condensation.
Using high-efficiency Fmoc chemistry on customized resin substrates (such as CTC resin or Sieber Amide resin), sequential coupling of protected amino acids is executed in automated multi-liter peptide reactors. Critical non-natural amino acids, including Alpha-aminobutyric acid (Aib) residues at specific positions (which confer resistance to Dipeptidyl Peptidase-4 cleavage), are introduced using optimized sterically hindered coupling reagents (HATU, PyBOP) to guarantee coupling efficiencies exceeding 99.2% per cycle.
The attachment of the C20 diacid chain to Lysine-20 requires orthogonal protection group strategies (e.g., Lys(Dde) or Lys(Mtt)). Following selective deprotection of the Lysine side-chain, the gamma-Glu-2xOEG linker and eicosanedioic acid monomethyl ester are coupled step-wise under precise temperature control. This site-specific acylation ensures that the lipophilic tail is selectively positioned without disrupting key N-terminal residues critical for dual receptor binding.
Following total peptide cleavage from the resin matrix using tailored cleavage cocktails, raw Tirzepatide undergoes preparative Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) utilizing axial compression columns. Because residual TFA used during cleavage can cause local tissue irritation upon injection, Gentolex implements a dedicated acetate or chloride counter-ion exchange chromatography step, lowering TFA content to less than 1.0% (w/w)—well within strict regulatory and clinical standards.
For clients requiring finished dosage forms (FDF), raw Tirzepatide API is reconstituted with pharmaceutical-grade excipients (e.g., mannitol, sodium phosphate buffers) under Class 100 (ISO 5) aseptic conditions. Sub-zero flash freezing followed by multi-stage primary and secondary freeze-drying cycles yields stable, highly soluble 15mg cake structures with low residual moisture (< 2.0%), guaranteeing a shelf life of 24 months under refrigerated conditions (2°C to 8°C).
Connecting global biotech & pharmaceutical entities with guaranteed peptide products and full-spectrum CDMO support.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions for global pharmaceutical buyers.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Full documents and Certificates are supported to customers worldwide.
End-to-end technical R&D pipelines, sequence optimization, impurity isolation, structural characterization, and analytical method validation tailored for complex GLP-1/GIP analogs.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Overcoming purity degradation, batch inconsistency, regulatory bottlenecks, and temperature-controlled logistics.
Procuring high-value peptide APIs like Tirzepatide 15mg at commercial scale involves significant supply chain risks. Pharmaceutical buyers across North America, Europe, Latin America, and Africa face stringent regulatory scrutiny and strict technical standards. Below is how Gentolex mitigates buyer pain points through structured quality management:
In peptide synthesis, minor variations in temperature, reagent purity, or moisture can induce amino acid racemization or sequence deletions. Gentolex utilizes fully automated synthesis equipment with real-time process analytical technology (PAT). Every batch of Tirzepatide 15mg undergoes rigorous testing via RP-HPLC, LC-MS, MALDI-TOF, and capillary electrophoresis to ensure identity, purity, and structural integrity across multi-kilogram production lots.
Tirzepatide is temperature-sensitive in liquid matrix and requires carefully controlled environments even in lyophilized form. Gentolex packages Tirzepatide 15mg lyophilized vials and bulk powders in vacuum-sealed, tamper-evident glass vials packaged within thermal-insulated containers loaded with temperature data loggers. Partnering with elite logistics networks, we guarantee cold-chain transit (-20°C or 2-8°C) to client destinations in over 10 countries, including dedicated support hubs in Mexico and South Africa.
Navigating global regulatory landscapes requires comprehensive documentation. Gentolex supplies complete analytical packages with every shipment, including:
Discover our extended spectrum of active ingredients, therapeutic peptides, and fine chemical intermediates.
Operating in strict conformity with cGMP standards and international compliance benchmarks.
Explore the latest breakthroughs in neuroactive peptides, tissue regeneration, and mitochondria-targeting molecules.
Introduction to Selank Acetate API: Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a derivative of the endogenous...
View Details
Trusted Thymosin Beta-4 API Manufacturer and Global Peptide Supplier: As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, pharmaceutical research organizations, and li...
View Details
Introduction: BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, angiogenesis, and inflammatory regulation. As a peptide ac...
View Details
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation. Semax, a synthetic peptide derived from an ACTH fragment, has attracted attention among researchers due to its unique mol...
View Details
SS-31 (Elamipretide) API: SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane. By stabilizing mitochondrial structure and supporting cellular bioenergetics, SS-31 ha...
View DetailsAddressing key procurement, quality control, analytical validation, and commercial licensing queries.
